175137-56-1 Usage
Description
2-(4-Bromo-3,5-dimethyl-1H-pyrazol-1-yl)ethanohydrazide is a chemical compound characterized by the molecular formula C8H12BrN5O. It is a hydrazide derivative featuring a pyrazole ring, which is often found in pharmaceutical research and drug development. 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ETHANOHYDRAZIDE is recognized for its potential to act as an inhibitor or ligand for various biological targets, making it a valuable asset in the search for new therapeutic agents.
Uses
Used in Pharmaceutical Research:
2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ETHANOHYDRAZIDE is used as a research compound for its potential to interact with specific molecular targets, which can be crucial in the development of new drugs and therapies.
Used in Drug Development:
In the pharmaceutical industry, 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ETHANOHYDRAZIDE is utilized as a potential inhibitor or ligand, contributing to the advancement of novel treatments for a range of diseases and disorders.
Safety Considerations:
Due to its potential hazards and toxicity, it is essential to handle 2-(4-BROMO-3,5-DIMETHYL-1H-PYRAZOL-1-YL)ETHANOHYDRAZIDE with care and adhere to proper safety protocols to minimize risks during its use in research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 175137-56-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,1,3 and 7 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 175137-56:
(8*1)+(7*7)+(6*5)+(5*1)+(4*3)+(3*7)+(2*5)+(1*6)=141
141 % 10 = 1
So 175137-56-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H11BrN4O/c1-4-7(8)5(2)12(11-4)3-6(13)10-9/h3,9H2,1-2H3,(H,10,13)
175137-56-1Relevant articles and documents
NOVEL HETEROARYL COMPOUND, ENANTIOMER, DIASTEREOMER OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND ANTIVIRAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT
-
Paragraph 0761; 0762; 0765; 0766, (2020/02/14)
The present invention relates to a novel heteroaryl compound, an enantiomer, a diastereomer or a pharmaceutically acceptable salt thereof, and an antiviral composition comprising the same as an active ingredient. The novel compounds represented by formula (I) or formula (II) according to the present invention are remarkably superior in antiviral activity against an influenza virus, and furthermore, have low cytotoxicity and thus low adverse effects on a human body. Therefore, a pharmaceutical composition containing the same as an active ingredient can be effectively used for the prevention or treatment of diseases caused by an influenza virus infection.
